Autophagic pathways cross with lipid homeostasis and thus provide energy and essential
building blocks that are indispensable for liver functions. Energy deficiencies are …

Inflammation has been reported to be intimately linked to the development or worsening of
several non-infectious diseases. A number of chronic conditions such as cancer, diabetes …

Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an unabated risk factor
for end-stage liver diseases with no available therapies. Dysregulated immune responses …

Much evidence has accumulated in the literature over the last fifteen years that indicates
vitamin A has a role in metabolic disease prevention and causation. This literature proposes …

Nonalcoholic fatty liver disease (NAFLD) comprises fat-accumulating conditions within
hepatocytes that can cause severe liver damage and metabolic comorbidities. Studies …

In clinical practice, combined heart and liver dysfunctions coexist in the setting of the main
heart and liver diseases because of complex cardiohepatic interactions. It is becoming …

Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide
with a complex etiology attributed to behavioural, environmental, and genetic causes. The …

Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease and it
encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, or cirrhosis. The …

Nonalcoholic fatty liver disease (NAFLD), also named metabolic dysfunction-associated fatty
liver disease (MAFLD), is a progressive disease spectrum encompassing simple steatosis …